Última Hora: "Farmácias têm prejuízo com medicamentos comparticipados - ECO Economia Online" Tue, 25 Sep 2018 15:46:28 GMT    "Nissan recolhe mais de 1.200 veículos por defeito no 'airbag' - Dinheiro Vivo" Tue, 25 Sep 2018 13:27:18 GMT    "Saída de cofundadores do Instagram atingem ações do Facebook - Ultimoinstante" Tue, 25 Sep 2018 13:18:53 GMT    "Faria de Oliveira: Legislador colocou bancos portugueses "em desvantagem competitiva" - Jornal de Negócios - Portugal" Tue, 25 Sep 2018 11:02:00 GMT    "EDP vai publicar dados da produção online - Jornal de Negócios - Portugal" Tue, 25 Sep 2018 14:04:38 GMT    "?Cloud? da Amazon abre escritório em Lisboa - Dinheiro Vivo" Tue, 25 Sep 2018 08:25:56 GMT   "" Tue, 25 Sep 2018 16:47:27 GMT    "Miguel Barreto foi escolhido para diretor-geral da Energia porque não era do setor - Observador" Tue, 25 Sep 2018 12:20:03 GMT    "Défice melhora 1,4 mil milhões de euros até agosto - Correio da Manhã" Tue, 25 Sep 2018 15:43:09 GMT    "Banqueiros rejeitam que haja bolha no mercado imobiliário - Dinheiro Vivo" Tue, 25 Sep 2018 14:55:00 GMT      Para mais notícias, clique aqui.

Área de Acesso
       
       
Lembrar Sempre 
(Login BolsaPT & Canal Forex)

Sem variação
Sepracor Inc. - [Ticker: SEPR]Gráfico Sepracor Inc.  Notícias Sepracor Inc.  Download de Históricos Metastock Sepracor Inc. e Outros  Análise Técnica Sepracor Inc.  
Última Trade0,000Range 52 Semanas[0,000 - 0,000]
Hora da Última Trade - 00:00:00Price-Target 1 Ano0,000
VariaçãoN/A (N/A)Capitalização Bolsista0
Bid / AskN/AEPS0,00
Abertura0,000PER0,00%
Máximo0,000Pagamento Dividendo
Mínimo0,000Data Ex-Dividendo
Fecho Anterior0,000Yield
Volume0Volume Médio (3m)0
Nota: Os dados podem apresentar atraso de alguns minutos.
Ver cotações de outros activos

Intraday   5 dias   1 mes   3 meses   6 meses   1 ano   2 anos   5 anos   10 anos            Use este gráfico no seu website!
Gráfico de Sepracor Inc. -  [Ticker: SEPR]
Mudar para Gráfico de Análise Técnica Interactiva de Sepracor Inc.

Últimos 10 Tópicos no Fórum sobre Sepracor Inc.:
Não foram encontrados tópicos sobre Sepracor Inc. [SEPR], mas aconselha-se pesquisa no Fórum por tópicos relacionados com Sepracor Inc..

 Notícias sobre Sepracor Inc. [SEPR]:   (ordenadas por relevância)

Paris Ledger

Global Asthma Medication Market Analysis 2018-2025 : Dulera, Merck, Roche, Sepracor, Sanofi
Paris Ledger
The competitive analysis contains identifying the key common trends and major players in the market such as [Dulera, QVAR, Glaxosmithkline plc, MAP Pharmaceuticals,Inc, Merck & Co. Inc, AstraZeneca plc, Roche Holdings Ltd, Genentech Inc, Sepracor, Inc, ...

e mais »

Florida Daily Chronicle

Global Desloratadine Market Study 2018- Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor ...
Florida Daily Chronicle
The well-established players in the market are Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, Nanjing Hicin ...


Medgadget (blog)

Obstructive Lung Disease Market 2018 Epidemiology, Drugs Uptake, Upcoming Therapies and Highly Analysed ...
Medgadget (blog)
(U.S.), Genentech Inc. (U.S.), Sepracor, Inc. (U.S.), Skyepharma plc (U.S.). Global Obstructive Lung Disease Market: Segmentation. The obstructive lung disease is segmented on the basis of disease type, product type, drug class, route of administration ...

e mais »

Find Market Research By Abhishek Budholiya (press release) (blog)

Allergy Treatment Market to Penetrate Untapped Regions During 2016 ? 2026
Find Market Research By Abhishek Budholiya (press release) (blog)
... treatment market are Allergy therapeutics, Allergopharma, Allergon AB, Alerpharma S.A, Allergan, Inc., Genentech Inc., Schering-Plough Corporation, McNeil Consumer Healthcare, Collegium Pharmaceutical, Inc., Meda Pharmaceuticals, Inc, Sepracor, Inc.


Three PM News (blog)

Global Desloratadine Market 2018 Major Players ? Hairui Pharmaceutical, Mayne Pharma Inc, Pfizer, Sepracor, Mylan ...
Three PM News (blog)
Global Desloratadine Market Research Report 2018-2023 published and promoted by GenMarketInsights.com provides in-depth segment analysis of the market being effective in several sectors, thereby providing valuable insights to the rivals.


Photocure ASA: Daniel Schneider appointed Chief Executive Officer
GlobeNewswire (press release)
Mr Schneider has also held executive management positions in other pharmaceutical and biotech companies, including BTG International, Somaxon Pharmaceuticals and Sepracor. ... The US headquarters for Photocure Inc., are in Princeton, New Jersey.

e mais »

The Business Investor

Global Asthma Medication Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 ? 2025
The Business Investor
Global Asthma Medication market is valued at USD XX million in 2018 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2018 and 2022. Asthma is chronic inflammatory lung disease. Asthma affects the ...


Tactical Business

Asthma Medication-Global Market Outlook 2018-2025
Tactical Business
Global Asthma Medication Market : This report studies the global market size of Asthma Medication in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Asthma Medication ...

e mais »

managementjournal24.com

Asthma Medication Market to 2025 ?Global Market Size, Development Status, Top Manufacturers, and Forecasts
managementjournal24.com
Global Asthma Medication market Review Forecast to 2023 ? Analysis by Chemical Type, Technology, Application, End-User, Industry Vertical, and Region' into its vast depository of research reports. In the first section of the report, the market ...

e mais »

Desloratadine Market Analysis, Overview, Growth, Demand and Forecast Research Report to 2025
Chronicle India
Top Key Players of Desloratadine Market: Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, Nanjing Hicin ...


CB Reporter

Worldwide Desloratadine Market Research Report 2018: Progress, Size, Share, Development, Trends And Estimates ...
CB Reporter
Desloratadine Market Segment by Manufacturers includes: Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, ...

e mais »

Global Desloratadine Market Growth Trends,Type ,Application , Revenue ,Size ,Demand , Research Approach and ...
Trade Market Research
Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, Nanjing Hicin Pharmaceutical, Hairui Pharmaceutical, Hainan ...

e mais »

Global Desloratadine Market Research Study including Growth Factors, Types and Application by regions from 2017 to ...
Chronicle India
Desloratadine Market report offers an inclusive and decision-making overview, including definitions, classifications and its applications. The Desloratadine market is anticipated to reflect a positive growth trend in forthcoming years. The essential ...

e mais »

Asthma Medication Market Insights, Forecast to 2025 Market By Manufactures, Product scope and Trends 2018 to 2023
theperfectinvestor.com
Global Asthma Medication Market Insights, Forecast to 2025 Market Professional Survey Report 2018?provides strategists, marketers and senior management with the critical information they need to assess the global Asthma Medication Market Insights, ...

e mais »

BSA bureau (press release)

Sumitomo Dainippon appoints Nomura as President & CEO
BSA bureau (press release)
In 2010, Sunovion (formerly Sepracor Inc.), was acquired by Sumitomo Dainippon. Nomura took the position of the Vice Chair, Executive Vice President and CFO, Sunovion Pharmaceuticals Inc. in 2012. Following 2014, he became associated with the ...

e mais »
Para mais notícias sobre Sepracor Inc. clique aqui:
Notícias de Sepracor Inc.

Largura do Site:

 Imagem de Fundo:

Copyright@1998-2018 - BolsaPT.com, todos os direitos reservados.
Fórum de Bolsa Cotações de Bolsa Notícias de Bolsa Chat de Bolsa Disclaimer Recursos para Webmasters